OTTAWA, March 15, 2012 /CNW/ - The Honourable Leona Aglukkaq, Minister
of Health, announced today a renewed partnership between the Government
of Canada and Canada's Research-Based Pharmaceutical Companies (Rx&D)
to strengthen clinical research in Canada.
"Our Government is proud to support research that will deliver better
treatments and better care for Canadians," said Minister Aglukkaq.
"This partnership will enhance Canada's reputation as world-class
centre for clinical research and ensure new findings are applied to bed
side care, for patients."
The partnership between the Canadian Institutes of Health Research
(CIHR) and Rx&D seeks to strengthen Canada's position as a preferred
location to conduct clinical research. The partnership will play a key
role in the implementation of the Strategy for Patient-Oriented Research, a national initiative to ensure better translation of research findings into clinical practice.
Minister Aglukkaq announced the strategy last August - and it will
result in better alignment of research efforts with patients needs.
Through this partnership, CIHR and Rx&D member companies will fund
clinical research across Canada through a competitive, peer-reviewed
process and to improve the coordination of research activities. Rx&D
member companies have set an objective to match CIHR clinical research
Dr. Alain Beaudet, President of CIHR, added "This partnership will
better integrate health research and health care. By bringing together
researchers and industry, this partnership will accelerate the
development of new clinical practices and health products which will
have a direct impact on treatment and services provided to patients."
Over the last ten years, CIHR and Rx&D have partnered on a collaborative
research funding program. This program has supported a wide range of
health research projects at universities and hospitals across Canada.
They have led to significant research discoveries making a difference
in patients' lives today.
"The innovative pharmaceutical industry plays a critical role in the
discovery and development of medicines and vaccines that improve and
save lives," said Russell Williams, President of Rx&D. "It is our
goal, through this partnership, to outpace global competition and to
build Canada's position as a leader in clinical research, to create
jobs and increase R&D investments in Canada for the benefit of all
The Canadian Institutes of Health Research (CIHR) is the Government of
Canada's health research investment agency. CIHR's mission is to create
new scientific knowledge and to enable its translation into improved
health, more effective health services and products, and a strengthened
Canadian health care system. Composed of 13 Institutes, CIHR provides
leadership and support to more than 14,100 health researchers and
trainees across Canada. www.cihr-irsc.gc.ca
Rx&D is the association of leading research-based pharmaceutical companies
dedicated to improving the health of Canadians through the discovery
and development of new medicines and vaccines. Our community represents
15,000 men and women working for 50 member companies and invests more
than $1 billion in research and development each year to fuel Canada's
knowledge-based economy. Guided by our Code of Ethical Practices, our
membership is committed to working in partnership with governments,
healthcare professionals and stakeholders in a highly ethical manner.
Ce document est également disponible en français.
Renewal of CIHR/Rx&D Collaborative Research Program
Through the renewed collaborative agreement, CIHR is doubling its
investments of up to $150 million, with a complementary objective from
Rx&D members to match this contribution dollar for dollar over the next
five years. Via the CIHR/Rx&D Collaborative Research Program, both
organizations will optimize their research efforts. The partnered
program will lead to new clinical practices, innovative health policies
and better health care for all Canadians.
CIHR and Rx&D share the vision that Canada has a vibrant environment for
conducting internationally competitive research and accelerating the
commercialization of new knowledge for the benefits of Canadians and
others around the world. Canada's competitiveness depends on the steady
entry of highly skilled graduates into the many areas of health
research, such as clinical research. One of the main goals of this
agreement will be to develop and implement mechanisms to support,
train, recruit and retain outstanding researchers such as clinical
investigators, biostatisticians, methodologists, epidemiologists,
health economists, and technicians.
Additionally, this agreement will help solidify Canada's clinical
research environment by facilitating increased and sustained
investments and by bringing key partners together to identify and
pursue new research opportunities. It will enhance coordination at the
national, provincial and regional levels and simultaneously reduce
barriers and red tape for clinical researchers.
The goals of the agreement are to:
improve the coordination of key clinical research activities;
develop and implement mechanisms to effectively support, train, recruit
and retain outstanding researchers; and
catalyze clinical research and research training.
This partnership will align with the national Strategy for
Patient-Oriented Research led by CIHR. For more information about the
Strategy, visit: www.cihr.gc.ca/e/41204.html
Image with caption: "The Honourable Leona Aglukkaq, Minister of Health, announced today a renewed partnership between the Government of Canada and Rx&D to strengthen clinical research in Canada. Minister Aglukkaq made the announcement at the University of Ottawa Heart Institute. She is seen here visiting the Ruddy Canadian Cardiovascular Genetics Centre. (CNW Group/Canadian Institutes of Health Research)". Image available at: http://photos.newswire.ca/images/download/20120315_C4695_PHOTO_EN_11198.jpg
SOURCE Canadian Institutes of Health Research
For further information:
Cailin Rodgers, Office of the Honourable Leona Aglukkaq, Minister of Health 613-957-0200
David Coulombe, Media Relations, CIHR, 613-941-4563, email: email@example.com
Christine Choury, Media Relations, Rx&D, 613-236-0455 ext. 831, email: